Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Cuschieri

Showing results (31-40 of 132) with videos related to

Pageof 14
Sort By:
Expert Review of Molecular Diagnostics|May 1, 2019
Accuracy of genotyping for HPV16 and 18 to triage women with low-grade squamous intraepithelial lesions: a pooled analysis of VALGENT studiesLan Xu, Ina Benoy, Kate Cuschieri, et al.
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|March 26, 2021
Impact of the COVID-19 pandemic on human papillomavirus-based testing services to support cervical cancer screeningMario Poljak, Kate Cuschieri, Dur-E-Nayab Waheed, et al.
Journal of Medical Virology|October 22, 2013
Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical diseaseGeorge Chambers, David Millan, Kate Cuschieri, et al.
Vaccine|August 11, 2024
Assessing real world vaccine effectiveness: A review of Scotland's approach to monitoring human papillomavirus (HPV) vaccine impact on HPV infection and cervical diseaseRoss L Cameron, Tim J Palmer, Kate Cuschieri, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 22, 2024
2023 global inventory of commercial molecular tests for human papillomaviruses (HPV)Mario Poljak, Anja Oštrbenk Valenčak, Kate Cuschieri, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 10, 2023
The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysisHana Elasifer, Maria Maija N Amukwaya, Ramya Bhatia, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 16, 2021
Age-specific outcomes from the first round of HPV screening in unvaccinated women: Observational study from the English cervical screening pilotMatejka Rebolj, Christopher S Mathews, Francesca Pesola, et al.
BMJ (Clinical Research Ed.)|May 31, 2022
Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot dataMatejka Rebolj, Kate Cuschieri, Christopher S Mathews, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 6, 2024
Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screeningAnja Oštrbenk Valenčak, Kate Cuschieri, Linzi Connor, et al.
Journal of Medical Virology|September 15, 2011
Urine testing as a surveillance tool to monitor the impact of HPV immunization programsKate Cuschieri, Rak Nandwani, Pauline McGough, et al.
Pageof 14

Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
Expert Review of Molecular Diagnostics|May 1, 2019
Accuracy of genotyping for HPV16 and 18 to triage women with low-grade squamous intraepithelial lesions: a pooled analysis of VALGENT studiesLan Xu, Ina Benoy, Kate Cuschieri, et al.
Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica|March 26, 2021
Impact of the COVID-19 pandemic on human papillomavirus-based testing services to support cervical cancer screeningMario Poljak, Kate Cuschieri, Dur-E-Nayab Waheed, et al.
Journal of Medical Virology|October 22, 2013
Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical diseaseGeorge Chambers, David Millan, Kate Cuschieri, et al.
Vaccine|August 11, 2024
Assessing real world vaccine effectiveness: A review of Scotland's approach to monitoring human papillomavirus (HPV) vaccine impact on HPV infection and cervical diseaseRoss L Cameron, Tim J Palmer, Kate Cuschieri, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 22, 2024
2023 global inventory of commercial molecular tests for human papillomaviruses (HPV)Mario Poljak, Anja Oštrbenk Valenčak, Kate Cuschieri, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 10, 2023
The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysisHana Elasifer, Maria Maija N Amukwaya, Ramya Bhatia, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 16, 2021
Age-specific outcomes from the first round of HPV screening in unvaccinated women: Observational study from the English cervical screening pilotMatejka Rebolj, Christopher S Mathews, Francesca Pesola, et al.
BMJ (Clinical Research Ed.)|May 31, 2022
Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot dataMatejka Rebolj, Kate Cuschieri, Christopher S Mathews, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 6, 2024
Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screeningAnja Oštrbenk Valenčak, Kate Cuschieri, Linzi Connor, et al.
Journal of Medical Virology|September 15, 2011
Urine testing as a surveillance tool to monitor the impact of HPV immunization programsKate Cuschieri, Rak Nandwani, Pauline McGough, et al.
Pageof 14